Recordings
Now more than ever, businesses need to be resilient and plan for their future. Businesses must ensure that their IP strategy is aligned with their commercial goals, both to maximise profitability and to mitigate risk. This joint webinar with Hyperdrive, the NEAA and Mathys & Squire partners Sean Leach and Andrew White, explores how to do this in practice.
Following on from part one, in this webinar Mathys & Squire attorneys Peter Arch and Alexander Robinson take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.
The first of a two part series, this webinar, presented by Mathys & Squire attorneys Peter Arch and Alexander Robinson, provides an introduction to the basic requirements for obtaining SPC protection, the types of products which can be protected, and the scope and duration of protection.
In this webinar, Mathys & Squire attorneys Sean Leach and Andrew White explore the different ways that IP can be used strategically, including controlling commercial risk from third party IP, increasing market share and generating revenue from new markets, exploiting IP assets, and creating an IP strategy.
The European Patent Office (EPO) takes a different approach to the US PTO when considering obviousness/inventive step in antibody cases. In this webinar, Mathys & Squire partners Martin MacLean and Hazel Ford discuss the arguments that are most likely to be effective when addressing inventive step objections at the EPO, focusing on the field of antibodies.
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.